Bio-Rad Laboratories (BIO) Invested Capital (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Invested Capital for 18 consecutive years, with $8.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital rose 5.37% year-over-year to $8.8 billion in Q2 2026; TTM through Jun 2026 was $8.8 billion, a 5.37% increase from a year earlier, with the FY2025 full-year figure at $8.7 billion, up 11.41% from the prior year.
• Invested Capital was $8.8 billion for Q2 2026 at Bio-Rad Laboratories, up from $8.5 billion in the prior quarter.
• Over five years, Invested Capital peaked at $11.4 billion in Q1 2022 and troughed at $7.8 billion in Q4 2024.
• A 5-year average of $9.3 billion and a median of $9.2 billion in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slumped 36.95% in 2022 and climbed 11.41% in 2025, its largest moves.
• Over 5 years, Invested Capital stood at $10.8 billion in 2022, then fell by 8.07% to $9.9 billion in 2023, then dropped by 21.83% to $7.8 billion in 2024, then grew by 11.41% to $8.7 billion in 2025, then climbed by 1.39% to $8.8 billion in 2026.
• The last three Invested Capital figures came in at $8.8 billion (Q2 2026), $8.5 billion (Q1 2026), and $8.7 billion (Q4 2025), per Business Quant data.